Medical costs across Southeast Asia will surge by up to 21 per cent in 2025, forcing insurers and healthcare operators to replace traditional fee-for-service billing models with bundled pricing and tighter network controls.

Forecasts compiled by Mercer Marsh Benefits show medical trend rates hitting 21 per cent in the Philippines, 19 per cent in Indonesia, and 15 per cent in both Malaysia and Vietnam. These double-digit increases run well ahead of headline consumer price inflation across the region, putting immediate strain on corporate benefits budgets and personal household finances.

An estimated 25 per cent of all healthcare expenditure across Asian markets stems directly from administrative and clinical waste. This inefficiency includes unnecessary surgical interventions, prolonged hospital stays, inappropriate antibiotic prescriptions, and inadequate preventive screenings.

Payor-provider alignment could help eliminate redundant treatment cycles by linking compensation to clinical outcomes rather than the volume of procedures billed. Under the traditional fee-for-service structure, private hospitals and clinics face financial incentives to run additional diagnostic tests and extend inpatient admissions regardless of clinical necessity.

Addressing these inefficiencies requires insurers and medical providers to standardise diagnostic and clinical data at the line item level. Sharing harmonised laboratory results, procedure codes, and diagnostic files across private networks reduces duplicate testing and accelerates claims adjudication.

Rising medical costs are shifting directly onto consumers across developed and emerging economies alike. World Health Organisation figures cited by AIA show personal out-of-pocket healthcare expenditure jumped 13 per cent in both Singapore and Australia between 2022 and 2023.

Source link